[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Laurene E. Peck, Vice President, Chief Accounting Officer & Corporate Controller of Clorox Co. (CLX), reported an acquisition on 09/16/2025 of 1,441 shares of common stock via restricted stock units at an attributable price of $124.85 per share. After the transaction Ms. Peck beneficially owned 5,821 shares directly and 100 shares indirectly through a trust of a parent. The restricted stock units vest in four equal installments on October 5 of 2026, 2027, 2028 and 2029. The Form 4 was signed by an attorney-in-fact on 09/18/2025.

Positive

• Acquisition reported: 1,441 restricted stock units acquired, showing executive alignment with shareholder interests
• Multi-year vesting: RSUs vest in four equal installments on October 5, 2026, 2027, 2028 and 2029, supporting retention

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider acquisition of 1,441 RSUs shows executive alignment but is modest in size versus typical companywide holdings.

The reported transaction is an acquisition of restricted stock units rather than an open-market purchase, executed at $124.85 per share and scheduled to vest over four years. Such grants are routine compensation tools that align senior executives with shareholder outcomes and encourage retention. The post-transaction direct ownership of 5,821 shares provides context on Ms. Peck's current stake but does not on its own indicate material change to ownership concentration or control.

Corporate Governance Expert

TL;DR: A standard executive RSU award with multi-year vesting, reinforcing retention incentives and typical governance practice.

The four-year vesting schedule (annual installments beginning 10/05/2026) is consistent with common executive compensation design to promote long-term focus. Filing compliance appears proper with timely disclosure by Form 4. No information in the filing suggests extraordinary governance actions, change in responsibilities, or potential conflicts beyond standard indirect ownership via a parental trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Peck Laurene E

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP - CAO & Corp Controller

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		A(1)		1,441	A	$124.85	5,821	D
Common Stock								100	I	Trust of Parent

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028 and 2029.

	By Jinho Joo, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CLX insider Laurene Peck acquire on 09/16/2025?

She acquired 1,441 shares via restricted stock units, recorded at an attributable price of $124.85 per share.

How many CLX shares does Laurene Peck beneficially own after this Form 4?

Following the reported transaction she beneficially owned 5,821 shares directly and 100 shares indirectly through a trust of a parent.

When do the restricted stock units vest for Laurene Peck's award?

The RSUs vest in four equal installments on October 5 of 2026, 2027, 2028 and 2029.

Was the Form 4 filed timely and who signed it?

The form lists the transaction date as 09/16/2025 and was signed by an attorney-in-fact, Jinho Joo, on 09/18/2025.

What is Laurene Peck's role at Clorox as stated on the Form 4?

She is listed as VP - CAO & Corporate Controller, reported as an officer of the issuer.